Embryo Health Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGenomic Prediction Inc.
About this trial
This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All couples of Caucasian or East Asian ancestry above the age of 18 who elect to have PGT-A as part of their IVF treatment cycle.
Disqualifiers
Any case where biological parental DNA is unavailable.
Any case involving PGT-M or PGT-SR.
Trial population
Patients undergoing IVF with preimplantation genetic testing for aneuploidies (PGT-A).
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Preimplantation Genetic Testing
Other interventionEmbryo biopsies will undergo preimplantation genetic testing for aneuploidies as per standard of care, and polygenic disease risk (PGT-P) will be computed for these samples.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Patients' interest in Preimplantation Genetic Testing for Polygenic Disorders
Patients' interest in obtaining information on their embryos' polygenic disease risk will be measured in a scale of 1-5. 1 being "Not interested" and 5 "highly interested".
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov